FP5Training site2001–2005
Lead discovery by virtual screening and high throughput medicinal chemistry.
FP5 — Improving Human Research Potential
- Duration
- 2001-10-01 → 2005-09-30
- EU contribution
- €288,000
- Participants
- 1
- Scheme
- BUR
Lines connect the coordinator with its partners.
Participants
- AVENTIS PHARMA RECHERCHE DEVELOPPEMENT S.A. · VITRY SUR SEINECoordinatorFrance
Links
Data: CORDIS, © European Union